...
首页> 外文期刊>Immunology: An Official Journal of the British Society for Immunology >Chronic lymphocytic leukaemia: Could immunological tolerance mechanisms be the origin of lymphoid neoplasms?
【24h】

Chronic lymphocytic leukaemia: Could immunological tolerance mechanisms be the origin of lymphoid neoplasms?

机译:慢性淋巴细胞性白血病:免疫耐受机制可能是淋巴样肿瘤的起源吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Immunological tolerance theory in chronic lymphocytic leukaemia (CLL): we suggest that B cells that express B-cell receptors (BCR) that recognize their own BCR epitopes are viewed by immune system as 'dangerous cells'. BCR autonomous signalling may induce constant receptor editing and mistakes in allelic exclusion. The fact that whole BCR recognizes a self-antigen or foreing antigen may be irrelevant in early B cell development. In early B cells, autonomous signalling induced by recognition of the BCR's own epitopes simulates an antigen-antibody engagement. In the bone marrow this interaction is viewed as recognition of self-molecules and induces receptor editing. In mature B cells autonomous signalling by the BCR may promote 'reversible anergy' and also may correct self-reactivity induced by the somatic hypermutation mechanisms in mutated CLL B cells. However, in unmutated CLL B cells, BCR autonomous signalling in addition to self-antigen recognition augments B cell activation, proliferation and genomic instability. We suggest that CLL originates from a coordinated normal immunologic tolerance mechanism to destroy self-reactive B cells. Additional genetic damage induced by tolerance mechanisms may immortalize self-reactive B cells and transform them into a leukemia.
机译:慢性淋巴细胞性白血病(CLL)的免疫耐受理论:我们建议表达B细胞受体(BCR)识别自身BCR表位的B细胞被免疫系统视为“危险细胞”。 BCR自主信号传导可能引起恒定的受体编辑和等位基因排除错误。整个BCR识别自身抗原或前抗原的事实可能与早期B细胞发育无关。在早期的B细胞中,通过识别BCR自身的表位诱导的自主信号传导模拟了抗原抗体的结合。在骨髓中,这种相互作用被视为对自身分子的识别并诱导受体编辑。在成熟的B细胞中,BCR的自主信号传导可能会促进“可逆的无反应”,并且还可以纠正突变的CLL B细胞中由体细胞超突变机制诱导的自我反应。但是,在未突变的CLL B细胞中,除了自身抗原识别外,BCR自主信号传导还增强了B细胞的活化,增殖和基因组不稳定。我们建议CLL源自协调正常免疫耐受机制,以破坏自我反应性B细胞。耐受机制引起的其他遗传损伤可能使自我反应性B细胞永生,并将其转化为白血病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号